This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris. The latest edition of EuroPCR delivered updates on technologies like intravascular lithotripsy (IVL), replacement heart valves, drug-eluting stents and many, many more innovative offerings. Usual suspects in the cardiovascular space like Edwards, Johnson & […]
Shockwave Medical
J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women
Johnson & Johnson MedTech‘s Shockwave Medical unit today announced study results highlighting the use of its IVL treatment in female patients. Shockwave announced 30-day primary endpoint results from the EMPOWER CAD study of its intravascular lithotripsy (IVL) therapy. It marks the first prospective, real-world percutaneous coronary intervention (PCI) study in female patients with complex, calcified coronary […]
J&J’s Shockwave enrolls first patient in novel forward IVL study
Johnson & Johnson MedTech‘s Shockwave Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter. FORWARD CAD, an FDA investigational device exemption (IDE) study, evaluates the safety and efficacy of the company’s latest intravascular lithotripsy (IVL) catheter. It aims to treat calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting. […]
J&J’s Shockwave Medical launches new IVL catheter
Johnson & Johnson MedTech‘s Shockwave Medical today announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter. The Javelin aims to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-balloon IVL platform delivers a similar safety and efficacy profile to its legacy catheters, bolstering […]
The biggest medtech M&A moves of 2024
In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Shockwave Medical’s Javelin IVL catheter meets primary trial endpoints
Johnson & Johnson MedTech‘s Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin catheter. Shockwave shared the first clinical outcomes associated with its Javelin peripheral intravascular lithotripsy (IVL) catheter system. It designed this novel, non-balloon-based lithotripsy platform to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease […]
The biggest cardiovascular tech stories from TCT 2024
The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]
Shockwave Medical completes enrollment in all-female IVL study
Shockwave Medical, now part of Johnson & Johnson MedTech, has completed enrollment for its Empower CAD all-female study on percutaneous coronary intervention (PCI) in complex calcific coronary disease. The Shockwave study aims to confirm the benefits of coronary intravascular lithotripsy (IVL) in women. Co-principal investigator Dr. Margaret McEntegart, director of Complex PCI and CTO programs […]
J&J’s Shockwave adds enhanced catheter to U.S. IVL portfolio
Johnson & Johnson MedTech‘s Shockwave Medical today announced the full U.S. launch of its Shockwave E8 peripheral IVL catheter. Santa Clara, California-based Shockwave launched the intravascular lithotripsy (IVL) catheter following FDA clearance. It designed the catheter to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD). That includes patients with […]
Johnson & Johnson completes $13B Shockwave Medical acquisition
Johnson & Johnson today announced it completed its $13.1 billion acquisition of Shockwave Medical. The company previously confirmed plans to buy the intravascular lithotripsy (IVL) technology maker in April. Media reports previously linked Johnson & Johnson with an interest in purchasing the intravascular lithotripsy (IVL) technology maker last year. Under the agreement, J&J acquired all outstanding […]
Shockwave Medical opens IVL production plant in Costa Rica that will add 1,200 jobs
Shockwave Medical (Nasdaq:SWAV) announced today that it opened a new production plant for its intravascular lithotripsy (IVL) technology in Costa Rica. The company shared news of the new plant, located in San José, in a post on LinkedIn. It marks another recent positive development for the company, which agreed to be acquired for $13.1 billion by […]
